American Journal of Cardiology
Volume 104, Issue 3 , Pages 343-348 , 1 August 2009

Relation of Drug-Eluting Stent Strut Distribution to Stent Thrombosis in Coronary Arteries

  • Maksymilian P. Opolski, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Radoslaw Pracon, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Gary S. Mintz, MD

      Affiliations

    • Cardiovascular Research Foundation, New York, New York
    • ,
  • Teruo Okabe, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Jerzy Pregowski, MD

      Affiliations

    • Catheterization Laboratory and Coronary Disease Unit, Institute of Cardiology, Warsaw, Poland
    • ,
  • Sung Yun Lee, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Eva C. van der Waal, MSc

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Lukasz Kalinczuk, MD

      Affiliations

    • Catheterization Laboratory and Coronary Disease Unit, Institute of Cardiology, Warsaw, Poland
    • ,
  • Probal Roy, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Kimberly A. Smith, BS

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Rebecca Torguson, BS

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Zhenyi Xue, MS

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Lowell F. Satler, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Kenneth M. Kent, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Augusto D. Pichard, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Ron Waksman, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Neil J. Weissman, MD

      Affiliations

    • Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • Corresponding Author InformationCorresponding author: Tel: 202-877-0223; fax: 202-877-0206

Received 24 January 2009 ,Revised 23 March 2009 ,Accepted 23 March 2009.

References 

  1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  2. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788–794
  3. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
  4. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–1113
  5. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis events with drug eluting stents. J Am Coll Cardiol. 2005;45:2088–2092
  6. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–1521
  7. Jeremias A, Sylvia B, Bridges J, Kirtane AJ, Bigelow B, Pinto DS, et al. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation. 2004;109:1930–1932
  8. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis (Results from a pooled analysis including 10 randomized studies). J Am Coll Cardiol. 2005;45:954–959
  9. Waters RE, Kandzari DE, Phillips HR, Crawford LE, Sketch MH. Late thrombosis following treatment of in-stent restenosis with drug eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv. 2005;65:520–524
  10. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol. 2004;43:1959–1963
  11. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995–998
  12. Okabe T, Mintz GS, Buch AN, Roy P, Hong YJ, Smith KA, et al. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol. 2007;100:615–620
  13. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent (Should we be cautious?). Circulation. 2004;109:701–705
  14. Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M, et al. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol. 2005;96:1251–1253
  15. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426–2434
  16. Schwarzmaier-D'Assie A, Karnik R, Bonner G, Vavrik J, Slany J. Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting. J Endovasc Ther. 2007;14:106–109
  17. Yagi S, Kimura T, Hayashi I, Nishiuchi T. Acute coronary syndrome due to hinge movement of a bare-metal stent. Int J Cardiol. 2008;123:e64–e66
  18. Shite J, Matsumoto D, Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J. 2006;27:1389
  19. Hasegawa T, Ako J, Ikeno F, Waseda K, Suzuki Y, Honda Y, et al. Comparison of nonuniform strut distribution between two drug-eluting stent platforms. J Invasive Cardiol. 2007;19:244–246
  20. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, et al. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation. 2004;110:3430–3434
  21. Sano K, Mintz GS, Carlier SG, Fujii K, Takebayashi H, Kimura M, et al. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. Am J Cardiol. 2006;98:1559–1562
  22. Mintz GS. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol. 2007;100(suppl):26M–35M
  23. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS) (A report of the American College of Cardiology task force on clinical expert consensus documents). J Am Coll Cardiol. 2001;37:1478–1492
  24. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, et al. Predictors and outcomes of stent thrombosis (An intravascular ultrasound registry). Eur Heart J. 2002;23:124–132
  25. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, et al. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol. 2007;100:628–630
  26. Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003;108:43–47
  27. Kim SW, Mintz GS, Ohlmann P, Hassani SE, Fernandez S, Lu L, et al. Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis. Am J Cardiol. 2006;98:1206–1211
  28. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202
  29. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007;28:961–967
  30. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–2441

PII: S0002-9149(09)00809-1

doi: 10.1016/j.amjcard.2009.03.047

American Journal of Cardiology
Volume 104, Issue 3 , Pages 343-348 , 1 August 2009

Article Tools

* Image Usage & Resolution